Skip to content

Clinical trials

Myocardial Infarction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Country / region: United States Clear all

405 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20017
20028
200323
20049
200520
200619
200720
200823
200916
201012
201120
201215
201320
201412
201521
201617
201717
201810
201912
202016
202110
20228
202313
202414
202511
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed266
Terminated43
Unknown status24
Active, not recruiting22
Recruiting22
Withdrawn15
Not yet recruiting8
Enrolling by invitation4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic17
Brigham and Women's Hospital12
National Heart, Lung, and Blood Institute (NHLBI)10
AstraZeneca9
Massachusetts General Hospital9
NYU Langone Health8
Johns Hopkins University6
Stanford University6
Weill Medical College of Cornell University6
Yale University6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction405
Coronary Artery Disease86
Cardiovascular Diseases71
Heart Failure62
Stroke61
Acute Coronary Syndrome53
Heart Diseases40
Myocardial Ischemia35
Angina, Unstable32
Atherosclerosis28

Trials

Showing 51 to 75 of 405. Each trial links to its page on Pharma Observatory.

305 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.